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Abstract
Our molecular simulations reveal that wild-type influenza fusion peptides are able to stabilize a highly fusogenic pre-fusion
structure, i.e. a peptide bundle formed by four or more trans-membrane arranged fusion peptides. We rationalize that the
lipid rim around such bundle has a non-vanishing rim energy (line-tension), which is essential to (i) stabilize the initial
contact point between the fusing bilayers, i.e. the stalk, and (ii) drive its subsequent evolution. Such line-tension controlled
fusion event does not proceed along the hypothesized standard stalk-hemifusion pathway. In modeled influenza fusion,
single point mutations in the influenza fusion peptide either completely inhibit fusion (mutants G1V and W14A) or,
intriguingly, specifically arrest fusion at a hemifusion state (mutant G1S). Our simulations demonstrate that, within a line-
tension controlled fusion mechanism, these known point mutations either completely inhibit fusion by impairing the
peptide’s ability to stabilize the required peptide bundle (G1V and W14A) or stabilize a persistent bundle that leads to a
kinetically trapped hemifusion state (G1S). In addition, our results further suggest that the recently discovered leaky fusion
mutant G13A, which is known to facilitate a pronounced leakage of the target membrane prior to lipid mixing, reduces the
membrane integrity by forming a ‘super’ bundle. Our simulations offer a new interpretation for a number of experimentally
observed features of the fusion reaction mediated by the prototypical fusion protein, influenza hemagglutinin, and might
bring new insights into mechanisms of other viral fusion reactions.
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Introduction
Membrane fusion is a fundamental process in biological cells,
being involved in viral infection, endo- and exocytosis, and
fertilization. The understanding of its molecular mechanism will
open avenues for controlling a variety of collective biophysical
processes that alter membrane topology. It is widely accepted that
influenza hemagglutinin mediates a fusion mechanism that
progresses through hemifusion [1,2]. In the standard stalk-
hemifusion pathway [3–5], illustrated in Fig. 1, the initial contact
point between the apposing cis-leaflets, i.e. the stalk, progresses via
an axially symmetric radial expansion (stalk widening), which thins
the stalk such that the two distal trans-leaflets eventually meet and
form a single-bilayer-thick H-shaped diaphragm (H-HD). After
rupture of the H-HD, the fusion is completed.
Conductance measurements and fluorescence spectroscopy
studies of fusion between the influenza envelope (host membrane)
and lipid model membranes (target membrane) have reported that
lipid mixing is preceded by the formation of an essential pre-fusion
structure in the target membrane [6–11]. Formation of such a pre-
fusion structure is believed to involve perforation of the target
membrane [6,7], because leakage through the target membrane is
detected prior to lipid mixing [6–8,11,12].
Intriguingly, the formation of a small (&5 nm wide) stable p-
shaped HD (p-HD), illustrated in Fig. 2, which appears to be
generated by a stalk that has partially encircled a formed
membrane pore, has recently been observed by electron cryo-
tomography of influenza fusion between a viral envelope and a
pure DOPC vesicle [7]. It was reported that a leaky funnel-like
structure was formed in the target membrane prior to lipid mixing.
Moreover, in this example, the trans-leaflet of the viral membrane
is completely covered by a rigid, shape-stabilizing protein matrix
[7], that impedes bending of the trans-leaflets, which is required for
the stalk to expand into an HD (Fig. 1 II) [4,13]. Such limitation
should have substantially increased the already large barrier to
form an H-HD within the standard hemi-fusion mechanism,
ranging from 15–63 kBT in free membranes without protein
matrix [4].
In model influenza fusion, single point mutations of the fusion
peptide have been shown to either completely inhibit fusion,
specifically arrest fusion at a hemifusion stage, or induce
pronounced leakage of the target membrane prior to lipid mixing
[11,14,15]. It is still puzzling why the fusion mechanism is so
sensitive to minor changes in the fusion peptide.
The important philosophy behind point mutations is that they
alter specific and essential peptide-membrane interactions and
thereby modify the ability to overcome free-energy barriers in the
underlying fusion mechanism of the wild-type peptide. Point
mutation studies therefore play a key role in unraveling the
mechanism of influenza fusion. It is reasonable to assume that, to
stabilize the initial stalk, fusion peptides should stabilize the
negatively curved stalk structure [3,4,13,16–20]. Experiments,
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neutral to weakly positively curved membrane structures, i.e. pores
and dimples but not stalks [15,21,22]. The latter would suggest
that the fusion peptides do not adhere to the negatively curved
circumference of the stalk, which is supported by recent molecular
simulations studies [23,24]. If the peptides do not directly stabilize
the stalk structure itself, it is plausible that they will promote the
formation of alternate, highly stressed pre-fusion structures, such
as a dimple and/or pore [6,7,16], that relax by both stabilizing
and expanding the stalk in the course of fusion. Could the fusion
inhibiting mutants G1V and W14A [14,25] impair the formation
of a required pre-fusion structure? Is the leakage of the target
membrane observed prior to lipid mixing, as induced by point
mutation G13A [11], possibly related to the corrupted formation
of such pre-fusion structure?
Other point mutations facilitate hemifusion but selectively
inhibit content mixing [11,14,15]. One of such intriguing point
mutations is mutant G1S. In comparison with the wild-type, this
Figure 1. Standard stalk-hemifusion pathway (cross-section, side-view): The initial stalk (I) radially expands (II) forming an H-
shaped hemifusion diaphragm (H-HD) after the trans-leaflets (colored yellow) meet (III). When the H-HD ruptures a fusion pore is formed
(IV).
doi:10.1371/journal.pone.0038302.g001
Figure 2. A p-shaped hemifusion diaphragm (p-HD) which is generated by a stalk that has encircled a membrane pore.
doi:10.1371/journal.pone.0038302.g002
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dynamics and, in addition, also inserts similarly in the membrane
[15]. It is difficult to conceive how the wild-type peptide, when
adhering to the membrane outside of the virus or host cell [15],
and when not being associated with the stalk structure [15,21–24],
would open the fusion pore. Is it possible that the terminal-
hemifusion mutant G1S rather inhibits the fusion step prior to
pore opening, i.e. the expansion of the stalk into a p-HD?
The aim of this work is to relate the three different
experimentally observed phenomena in influenza fusion: the
funnel-like pre-fusion structure, the p-HD and the observed effect
of the point mutations. We will demonstrate that these three
phenomena can be understood from a fundamental and general
concept in membrane physics: the line-tension, i.e. the free-energy
per unit length [26,27]. To this end, we use molecular simulation
of a coarse-grained model [28,29], where computational efficiency
is enhanced by representing several atoms by a single interaction
site. This description captures the underlying driving forces and
evolution of the fusion process in near-atomic detail. Recently, this
model has been successfully applied to study membrane fusion
mediated by SNARE proteins [30] and long surfactant protein B
[31]. To rationalize the above mentioned phenomena, we (i) study
the physical properties of an isolated stalk formed between two
apposing bilayers, (ii) investigate how these stalk properties are
modified by the presence of a small hydrophilic pore in one of the
bilayers, (iii) explore the relation between wild-type influenza
peptides and stalk expansion, and (iv) study the effects of point
mutations that are experimentally known to alter the peptide’s
fusogenity.
Results and Discussion
Large Negative Spontaneous Curvature Results in Linear
Stalk Elongation
Fusion is believed to be initiated by the formation of an
energetically costly negatively curved stalk structure [1–4,13,16–
20]. To be able to rationalize the link between stalk and line-
tension, we first study the expansion of an isolated stalk formed
between two tension-less lipid membranes of area 20|20 nm2
(1152 lipids each) that are separated by a 2 nm-thick water layer,
corresponding to approximately 16 H2O molecules per lipid. After
stalk formation, fusion has been proposed to progress by either a
radial, axially symmetric expansion [3,13,16,18] or, alternatively,
by a linear elongation of the stalk [13,19,32,33]. Lipids that are
characterized by a large negative spontaneous curvature, e.g.
DOPE lipids, form inverse lipid phases, e.g. the inverted
hexagonal phase, at sufficiently low hydration and high temper-
ature. The inverted hexagonal phase consists of an hexagonally
ordered array of cylindrical bilayer structures. As observed in both,
coarse-grained and atomistic simulations [34,35], inverted hexag-
onal structures are formed by linear elongation of stalks between
multiple stacked bilayers. This universal type of stalk instability
characterizes the transition from the lamellar to the inverted
hexagonal phase [36]. Such a linear elongation of a stalk is shown
in Fig. 3 C for a stalk formed between two DOPE bilayers at
350 K. We estimated the line-tension l, a measure for the free-
energy per unit length, of such a linearly elongated DOPE stalk
from the pressure tensor (see Fig. S1 for a detailed explanation)
and obtained l=260+15 pN or about 214 kBT per nm. A
negative line-tension implies that it is thermodynamically favor-
able to increase the negatively curved perimeter of the stalk, i.e.
stalk elongation. When we replace one of the DOPE bilayers by a
pure DOPC bilayer, however, stalk elongation is inhibited and the
initially formed ‘hour glass’-shaped (rhombohedral) stalk remains
stable over the course of the 4 ms simulation (see Fig. 3 B). The
latter effect can be explained by a positive value of l as a result of
the increasing fraction of DOPC lipids, which have a more
positive spontaneous curvature. Such asymmetric setup mimics the
experimentally studied fusion between a pure DOPC membrane
and the fusogenic viral envelope [7], where the occurrence of
spontaneous stalk elongation presumably is not favorable [37,38].
In such a case, a radial, axially symmetric stalk expansion,
stipulated by the standard hemifusion mechanism, becomes
favored over a linear expansion [13,33]. This latter process,
however, would face a substantial nucleation barrier that,
depending on lipid polymorphism, has been estimated to be 15–
63 kBT [4] and, indeed, such a radial stalk expansion is not
observed in our simulation. Thus, in the absence of a sufficiently
large negative spontaneous curvature, stalk expansion, either
radially or by elongation, does not occur spontaneously
[4,13,16,18,33,39].
The Presence of a Pore Results in the Formation of a p-HD
in Lamellar PC Bilayers
Alternative fusion mechanisms, which involve pores in one or
both of the apposing membranes have been observed in computer
simulation [5,32,40] and have been studied by self-consistent field
(SCF) theory [33]. Next, we study whether the presence of an
externally stabilized pore might overcome the free-energy cost of
stalk elongation even for more symmetric, lamella-forming lipids.
Since we focus on the stalk to HD transition, we do not investigate
the formation of a stalk in the vicinity of a pore or vice versa but we
start from the energetically favorable stalk-pore complex (Fig. 3 I)
[32]. To this end, we consider that a stalk has been formed
between two pure DOPC bilayers in the vicinity of a pore in the
lower bilayer. Panels I-III of Fig. 3 show that the presence of a
small 3 nm–wide pore, which is stabilized by an external field (cf.
methods), is indeed able to facilitate stalk elongation even between
lamella-forming DOPC bilayers at 310 & 350 K, and that such a
process leads to the formation of a p-HD. Note that this process
does not necessarily involve bending of the host membrane. Thus,
the presence of a rigid, shape-stabilizing protein-matrix on the
trans-leaflet of the viral envelope [7] would not impede such
formation of a p-HD.
It is easy to rationalize that the observed effect has a simple
essence. A pore generated in a lipid membrane, i.e. by membrane
stretching or application of an electric field, has a rim covered by
an extremely strongly curved lipid monolayer. The bending
energy of this monolayer determines the rim’s line-tension. Sewing
this rim to the host membrane replaces it with a circular three-
bilayer junction, which is energetically favorable and leads to p-
HD formation. We estimated the line-tension of the rim from the
simulation of the corresponding bilayer edge (mimicking a pore
with infinite radius) [41] and obtained lP~65+3 pN at 310 K.
Indeed, the line-tension of a three-bilayer junction (the HD) was
much lower, namely 23+10 pN (see Fig. S1). This value is in
qualitative agreement with values derived from continuum elastic
models (15–20 pN) [13]. Elongation is favorable, and the
metastable p-HD is formed, provided that the line-tension of the
three-bilayer junction is lower than that of the replaced pore edge.
Obviously, the topology of the fusion site resulting from such pore
fusion (a p-HD) is different from that generated by a dimple fusion
(an H-HD) but the physical forces are the same.
Finally, to demonstrate that the observed linear elongation of
the stalk crucially depends on the presence of a pore, we remove
the pore when the stalk has slightly elongated. In such a case, the
elongation reverses, and the stalk completely disappears (Fig. 4 I,
II, III). Thus, in the absence of a pore, stalk structures are not
Influenza Fusion Mechanism
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with 16 water molecules per lipid between the membranes), in
qualitative agreement with X-ray studies [42]. The latter process
might partly explain why lipid mixing in electrofusion is observed
after formation of membrane pores rather than the opposite [43].
Hence, stabilization of the stalk under unfavorable conditions, e.g.,
a non-optimal temperature, membrane curvature [16], hydration
level, or lipid composition, will necessarily require the presence of
the pore. We additionally note that the disappearance of the stalk
progressed through a similar intermediate as the one that has been
observed in simulations of stalk formation [30,44,44,45,45,46], i.e.
a splayed lipid connecting the two adjacent leaflets (seeFig. S2).
In summary, these stalk-pore simulations suggest that stalk
stabilization and expansion do not necessarily require the presence
of lipids with a negative spontaneous curvature but can
alternatively be facilitated by an external pore, whose curvature
stress gives rise to a positive line-tension. There is, however, one
conceptual difference: In our first example (Fig. 3 B & 3 C), the
stalk or elongated stalk was stabilized by the presence of the
intrinsic negatively curved DOPE lipids. In such a case, the DOPE
lipids were the ‘lineactants’ [47,48], i.e., molecules that favorably
partition towards the stalk’s perimeter and thereby reduce its
excess free-energy or line-tension. Likewise, also fusion peptides
are often thought to be ‘lineactants’. In our second example,
however, it was the stalk itself that was the lineactant, i.e. the stalk
favorably partitioned toward the pore’s rim and reduced its line-
tension. Could such inverted role, i.e. the stalk itself is the
lineactant, explain influenza fusion?
Influenza Fusion Peptides form a Trans-membrane
Arranged Peptide Bundle that Drives Stalk Elongation
Motivated by the experimental observation of a p-HD [7], and
the hypothesis of the funnel structure [6,7,9], we next address the
question of whether influenza peptides can, in principle, stabilize a
‘functional’ pre-fusion intermediate such as the pore shown in our
previous example. To this aim, we included a near-atomistic
coarse-grained model of the influenza hemagglutinin fusion
peptide [23,24]. This model accurately reproduces the general
structure of two helices joined by a linker region at a slightly bent
angle (Fig. 5 A) [15,25]. In addition, it successfully mimics the
amphiphilic nature of the influenza hemagglutinin fusion peptide.
Intriguingly, we observed that these fusion peptides possess a
Figure 3. Evolution of a stalk in the absence and presence of a pore. For sake of clarity the size of the lipid headgroups is exaggerated
(solvent is not shown). (A) Two apposed DOPC bilayers. A preformed stalk is not stable (see Fig. 4). (B) A stable ‘hour-glass shaped’ stalk structure
formed between a DOPE and DOPC bilayer (4 ms). (C) Elongation of a stalk formed between two DOPE bilayers (4 ms). (I-III) Evolution of a stalk formed
between two DOPC bilayers in the vicinity of a pore (stalk-pore complex). Elongation of the stalk, which circumvents the pore, results in the formation
of a p-shaped hemifusion diaphragm (p-HD).
doi:10.1371/journal.pone.0038302.g003
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arranged bundles consisting of 4–6 peptides (Fig. 5 B & methods).
These bundles were found to be stable in the course of a 10 m s-
lasting simulation. Such a peptide bundle conceptually differs from
the externally stabilized hydrophilic pore that we studied in our
previous example. The internal rim of the peptide ‘pore’ is lined
with the amphiphilic peptides that replace the lipid head groups
and solvent. The bundle’s interior is mainly composed of the
hydrophilic residues Glu11 and Asn12, which point toward the
central axis of the bundle (Fig. 5 C). This particular region in the
peptide, i.e. the kink region, has been shown to play a major role
in the peptide’s fusogenicity [11,15,25]. Such bundle structure is,
in fact, similar to the hexameric bundle formed by the related
parainfluenza virus 5 (PIV5) fusion peptide as observed in recent
atomistic simulations [9]. Such pore structure seems essentially
non-leaky and therefore rather resembles the closed structure of
the mechanosensitive channel protein MscL [9] than a hydrophilic
toroidal pore formed by antimicrobial peptides [49].
Although the peptide bundle is a self-stabilized structure, this
does not imply that the lipid rim that surrounds the bundle is
characterized by a vanishing excess of free-energy [50,51].
Assigning this quantity to the bundle circumference, we define
its line-tension. Whereas the line-tension of the hydrophilic pore in
our previous example was counter-balanced by an externally
applied potential, the line-tension of the rim of the peptide bundle
stems from a balance between the remaining hydrophobic
mismatch between peptides and lipids, and the short-range
repulsions (excluded volume) between the densely packed peptides
in the bundle. A non-vanishing positive line-tension is important:
(i) It can both stabilize and promote the expansion of the stalk, and
(ii) it favors minimization of the bundle’s perimeter and thereby
exerts a constricting force on the peptide bundle that ensures
formation of a closed, essentially non-leaky structure. If the peptide
bundle were an in-vivo relevant fusion intermediate the latter
would be important. Hence, like synaptic fusion, viral fusion is
generally believed to proceed via a non-leaky process, because
Figure 4. Stalk evolution in response of removing the pore (top view on porated bilayer). (I,II,III) Sudden removal of the pore before
completion of the p-HD reverses the stalk elongation process, and the stalk completely disappears (DOPC at 310 K, with 16 water molecules per lipid
between the membranes). Hydrophobic lipid tails are colored grey, polar-headgroups (DOPC) tan.
doi:10.1371/journal.pone.0038302.g004
Figure 5. (A) Overlap between the coarse-grained model (backbone red and side-chains yellow) of the wild-type influenza fusion
peptide and the NMR structure [71]. The two helices are joined by a linker region at a slightly bent angle (boomerang-shape). (B) The wild-type
influenza fusion peptides (side-chains not shown) aggregate into a stable hexameric bundle. The bundle interior is depleted in solvent (colored blue)
and lipid head groups. For sake of clarity, the first backbone residue (Gly1) is colored yellow. (C) Top view of the bundle. The bundle’s interior is
mainly composed of the hydrophilic residues Glu11 (colored blue) and Asn12 (colored green) that are located in the kinked region of the peptide and
which point toward the central axis of the bundle.
doi:10.1371/journal.pone.0038302.g005
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condition of the peptide bundle/pore further implies that the
effective, attractive medium-ranged peptide-peptide interactions,
which are gained when the bundle is assembled, exceed the induced
line-tension.
We simulated the fusion reaction between the two DOPC
membranes in the presence of the peptide bundle and explored if
such bundle can, in principle, stabilize the stalk and drive its
subsequent expansion. In 5 out of 5 simulations, stalk elongation
occurred as a nucleated event [32,33] within 4 ms. Fig. 6 A depicts
such elongation of the stalk in the presence of the peptide bundle
(see Fig. S4, for additional simulations). It appears that the
elongating stalk does not surround the bundle but rather ‘opens’
the closed bundle structure and pushes the peptides away. Such
nucleated opening of the bundle indicates that a stalk formed near
the intact bundle (Fig. 6 B) is under high stress, and vice versa. As
the stalk elongates, the free rim portion of the resulting stalk-pore
complex [33], which is not surrounded by the stalk, shrinks and
the peptides crowd in this location (Fig. 6 A). The elongated stalk
stabilizes a hydrophilic rim which is composed of lipid head groups
(i.e, the p-HD). In contrast, the free portion of the rim which is
stabilized by the peptides remains hydrophobic. Because the
peptides are forced in close contact with the ends of the stalk, they
might partly stabilize these ends by lowering their Gaussian
curvature energy [23,24,33,38]. The replacement of the peptides
by the stalk at the rim of such a pore further indicates (i) a non-
vanishing positive line-tension, (ii) a pronounced difference of line-
tension between its rim and the p-HD, and (iii) that the stalk is the
better lineactant, i.e. it has a higher affinity for its rim than the
peptides.
To conclude, our simulations suggest that the wild-type
influenza fusion peptide can in principle form a functional pre-
fusion intermediate [6,7,9], i.e. a bundle consisting of multiple
trans-membrane arranged fusion peptides, and that such an
intermediate can facilitate the subsequent formation of the
experimentally observed p-HD [7].
Point Mutations Affect Stability and Fusogenicity of the
Peptide Bundle
The relation between the peptide bundle and fusion is further
corroborated by studies of the influence of peptide mutations. We
discuss four specific examples:
(I) A point mutation (G1V) where the first residue in the peptide,
glycine, is replaced by valine, completely inhibits membrane fusion
(lipid mixing) [14]. When adhered to the membrane surface, the
fusogenic wild-type peptide adopts a boomerang shape (cf. Fig. 5
A), while the non-fusogenic G1V mutant remains linear, a-helical
[15]. It has been demonstrated by atomistic simulations that such
linear a-helical structure strongly reduces the peptides ability to
penetrate the hydrophobic membrane core [15], i.e., the peptides
remain parallel to the membrane surface. It is intuitive that the
inability of the G1V mutant to adopt a trans-membrane
orientation will also affect the formation/stabilization of the
observed peptide bundle.
We have performed simulations of wild-type peptides forming a
stable bundle (see methods). Then, the first residue, glycine, was
replaced with valine together with adapting the secondary
structure to the linear a-helical structure [15]. Such point mutation
rapidly destabilized the bundle in 5 out of 5 simulations (Fig. 7).
Thus, our simulations indicate that the G1V mutation indeed
impairs the ability of the peptides to form stable bundles. We
found this effect, however, to be independent of secondary
structure. Bundle destabilization also occurred when we conserved
the secondary structure of the wild-type. In contrast, the bundle
remained stable in the presence of fully linear, a-helical wild-type
peptides. We therefore relate the destabilization of the bundle to
the increased hydrophobicity of the first residue rather than the
concomitant change in secondary structure. This effect can be
rationalized by the reduced ability of the hydrophobic Val1
residue to line-up with both the lipid/solvent interface and the
hydrophilic center of the bundle (Fig. 5 B & C). However, the
boomerang shape of the wild-type [15,25] might help the peptides
to more easily adapt the trans-membrane orientation that is
required to form such bundle. Although the G1V mutation will
also affect other functions of these peptides related to fusion, e.g.
the formation of the dimple [7,52], the lipid protrusion frequency
[46], solvent dynamics [53], or membrane curvature/elasticity
[38], the important role of the bundle in the viral fusion process
indicated by our simulations suggests that the absence of a bundle
substantially affects both the stability of the initial stalk and the
pathway of the following fusion reaction. Aside from stabilizing the
stalk structure, a bundle also enhances formation of the stalk by
allowing a closer proximity between the adjacent fusion sites [39],
e.g., by locally perturbing the membrane structure and reducing
the inter-membrane repulsion (see Fig. S3). If viral fusion in model
systems proceeded only after the formation of an initial ‘funnel’
structure in the target membrane [6,7,9], the non-fusogenicity of
the point mutation could be rationalized by its inability to induce
this early step of the fusion process.
(II) Similar to mutant G1V, also mutant W14A has been shown
to inhibit lipid mixing [25]. The structure of W14A determined by
NMR and site-directed spin labeling features a flexible kink that
points out of the membrane, in sharp contrast to the more ordered
boomerang shape of the wild-type, which points into the
membrane [25]. Although the flexible structure of mutant
W14A rather differs from the conserved linear a-helical structure
of mutant G1V, we expect that also mutant W14A destabilizes the
bundle because it shares the inability of mutant G1V to induce
fusion. To this end, we modeled mutant W14A based on its NMR
derived structure (cf. methods) and studied its ability to stabilize the
bundle. Figure 7 shows that mutant W14A destabilizes the bundle
within 100 ns. Thus, the inability to stabilize the bundle seems
common to both of these structurally different point mutations.
(III) Another well known and intriguing point mutation of the
peptide, Gly1 to Ser1 (mutant G1S), facilitates lipid mixing but
selectively impairs its ability to complete fusion, i.e. content mixing
[14]. Combined NMR and atomistic simulation studies have
shown that this G1S mutant adopts a similar boomerang shape,
displays similar structural dynamics, and inserts similarly in the
hydrophobic bilayer core as the bundle-forming wild-peptide [15].
In contrast to mutant G1V, mutant G1S does not destabilize the
bundle over the course of all 5 simulations lasting 10 ms. Thus, our
simulations predict that also the G1S mutant is able to stabilize a
peptide bundle. The latter might be explained by the fact that,
unlike valine (mutant G1V), serine is even slightly more
hydrophilic than glycine (wild-type), which makes lining up with
both the hydrophilic center of the bundle and the lipid/solvent
interface energetically favorable. Thus, we assume that the G1S
mutant forms a stable bundle and, according to the here-proposed
stalk-bundle mechanism, such a bundle will, in turn, facilitate the
formation/stabilization of a stalk. This stalk-bundle formation is
corroborated by the experimentally observed lipid mixing [14].
How can this situation be reconciled with the peptide’s inability to
complete fusion? To this end, we investigated the behavior of a
stalk-bundle complex formed between two DOPC bilayers. We
observed that the presence of the G1S mutant bundle stabilizes the
stalk in the course of the simulation of 10 ms but, in contrast to the
bundle of wild-type peptides, the stalk does not ‘open’ the bundle
Influenza Fusion Mechanism
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observation suggests that the stresses imposed on the lipid rim of
the preserved bundle are either too small and/or the affinity
between the peptides in the bundle is too large. In other words
such closed bundle structure seems too favorable/stable with
respect to the elongated stalk. Since stalk elongation seems to be a
nucleated event that requires an initial ‘opening’ of the bundle
(Fig. 6A), the presence of a persistent bundle opposes stalk
elongation.
To further explore the stability of such bundle against stalk
elongation, we took a corresponding wild-type simulation where
nucleation of the elongation process had readily occurred, and ‘on
the fly’ mutated the wild-type into the G1S mutant. Intriguingly,
such mutation actually reversed the elongation process and
recovered the bundle (Fig. 8). This reversibility indicates that the
G1S mutation in fact makes stalk elongation a continuous
energetically ‘uphill’ process rather than a nucleated event, and
illustrates that the peptide and the stalk are competitive lineactants
– a hydrophobic lipid rim is a prerequisite for the peptide/bundle,
whereas a hydrophilic rim is a prerequisite for the elongated stalk
(Fig. 8). Apparently, the G1S mutant is the better lineactant, i.e. it
has the higher affinity for the lipid rim. The inability of the stalk to
elongate and form a p-HD imparts a higher barrier onto the fusion
process, which traps the membranes in an incomplete fusion state
in our simulation as well as in experiments [14]. We note that such
a trapped incomplete fusion state facilitates mixing predominantly
Figure 6. Evolution of the stalk in the presence of the peptide bundle. For sake of clarity the size of the lipid headgroups is exaggerated
(solvent is not shown). (A) The elongated stalk (wild-type peptides) after 0.4 ms. The bundle has opened up and the stalk and has partly surrounded
the formed hole. Notice the readily adopted banana-shape. The stalk forces the peptides to the remaining rim portion. At this stage mixing occurs
between both the cis-leaflets and the trans-leaflet of the target membrane (colored gray), while the cis-leaflet of the host cell (colored yellow) does
not contribute to lipid mixing. (B) Mutating a single residue in the peptides, Gly1 to Ser1 (colored green), known as the terminal hemifusion mutant
G1S [14,25], stabilizes both bundle and stalk but inhibits elongation of the stalk (10 ms). Consequentially, the fusion reaction becomes trapped. Note
that lipid head-groups are excluded from the pore interior and the trans-leaflets (colored yellow) are hindered from participating in the lipid mixing.
doi:10.1371/journal.pone.0038302.g006
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pathway (cf. Fig. 1 A) because lipid head-groups are excluded from
the interior of the preserved bundle structure and thereby hinder
the occurrence of flip-flops from the trans-t ocis-leaflets (Fig. 6B).
(IV) The last point mutation of interest is the recently discovered
mutant G13A [11]. Whereas the wild-type peptide has a steep
kink-angle of 105 degrees, mutant G13A has a shallower kink-
angle of about 150 degrees [11]. Fluorescence microscopy studies
have observed that when red blood cells expressing such mutant
merge, the content of the cells is released into the inter-cellular
space rather than being transferred between the fusing cells [11].
Such massive leakage is readily observed more than 5 minutes
before the occurrence of lipid mixing [11]. Leakage of the target
membrane prior to lipid mixing, albeit less pronounced, has also
been observed in model influenza fusion with wild-type peptides
[6,7,12].
Notably, there seems to be a close relationship between a
peptide’s ability to induce membrane lysis (leakage) and its ability
to induce fusion. Antimicrobial peptides such as melittin, which
are primarily pore-forming, have been shown capable to induce
fusion [54,55], whereas fusion peptides, such as influenza
hemagglutinin, have been shown capable to induce membrane
lysis [56–59]. Furthermore, it has been observed that deletion of
the N- or C-terminus of the influenza fusion peptide or its mutants,
decrease its ability to induce both lysis and fusion [56,57]. With
respect to the here-proposed stalk-bundle mechanism, such a
relationship is intuitive because both fusion and lysis relate to the
line-tension and the peptides are lineactants in both cases.
We explored the behavior of the bundles formed by mutant
G13A. To do so, we positioned 4 bundles, each consisting of six
trans-membrane arranged peptides plus two ‘bystander’ peptides,
in a 15615 nm POPC bilayer. We also duplicated this setup for
the wild-type bundles. Fig. 9 shows both setups. In the course of
the 20 ms simulation we observed a strong repulsive behavior
between the separate wild-type bundles, i.e. the bundles tend to
maximize their separation distance (Fig. 9, upper panel).
Eventually, one of the bundles breaks up and the peptides
redistribute among the remaining bundles. The size of these
bundles ranges from tetrameters to hexamers, with pentamers
being the most abundant (Fig. 9, lower panel). Notably, also the
surface adhered peptides display an interaction with the bundle
and likely play a role in its stability. In contrast to the wild-type
bundles, the bundles formed by mutant G13A are ‘attractive’ and
coalescence between the different bundles is observed (Fig. 9,
central panel). Eventually, the latter results in one large bundle
consisting of 10 trans-membrane arranged peptides and several
associated bystander peptides. Obviously, the formation of such a
‘super’ bundle would be ominous for the integrity of the
membrane (Fig. 10), especially in the presence of additional stress.
Thus, the action of mutant G13A, i.e. massive leakage prior to
lipid mixing, is very well explained by the formation of a corrupted
peptide bundle. How can we rationalize this effect? We
Figure 7. Point mutations that are known to inhibit fusion destabilize the bundle. (top) Mutating a single residue, Gly1 to Val1 (colored
blue), destabilizes the peptide bundle (mutant G1V). (bottom) Mutating a single residue, Trp14 to Ala14 (colored cyan), rapidly destabilizes the
peptide bundle (mutant W14A). Notice the flexible kink that points out of the membrane [25].
doi:10.1371/journal.pone.0038302.g007
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structure of the peptide, i.e. their mutual interactions and their
hydrophobic mismatch with the lipid membrane. The Janus-like
structure of the peptides and the concomitant directionality of
their mutual interaction is very important. If the peptides were
merely axially symmetric cylinders, the balance between their
mutual interaction and the hydrophobic mismatch (i.e. the
interaction with the lipids) would likely dictate clustering or
absence thereof [51]. In order to obtain a well-defined finite
aggregation number one needs either a special geometry of
packing or a special geometry of the interactions. The increased
hydrophobicity of residue 13 (Gly13 to Ala13), which directly faces
the lipid rim (Fig. 10), and the concomitant shallower kink-angle of
the peptide most likely changes the optimal packing within the
bundle and thereby drastically increases the aggregation number.
In support of these arguments, we note that the ‘super’ bundle
spontaneously reduces to its normal size after reversing the G13A
mutation (Fig. 9, lower panel). For a lineactant, there appears to be
a thin line between acting like a functional fusion peptide or
antimicrobial peptide [60]. The G13A mutant, however, seems to
behave more like an antimicrobial peptide.
In summary, our molecular simulations and free-energy
arguments in conjunction with experimental observations suggest
that the influenza fusion mechanism might proceed through the
formation of a trans-membrane arranged peptide bundle in the
target membrane [6,7,9]. We have shown that the lipidic rim
around a pore or peptide bundle is a critical factor in membrane
fusion, equivalent to membrane curvature, the commonly cited
determinant. In fact, curvature stress and line-tension are closely
related quantities in membrane physics. For example, in the
process of domain budding, minimization of the unfavorable
perimeter of raft domains drives membrane bending (budding) and
formation of vesicles (fission) [61]. Our simulations further suggest
that ‘fusogenic’ peptides strike a balance: On one hand, they
induce or stabilize a bundle in one of the membranes by gaining
relatively favorable peptide-peptide and peptide-lipid interactions.
On the other hand, the affinity of the peptides to pack into a
bundle should be smaller than the stalk’s affinity for the lipid rim
and the concomitant line-tension of the lipid rim has to be large
enough in order to allow the stalk to surround it and form a p-HD.
In addition, the peptide bundle should keep a low aggregation
number. Such a complex and subtle balance might very well
explain the experimentally observed sensitivity of the fusion
process towards point mutations in the influenza fusion peptide.
Based on our simulations, we predict that the puzzling trapped
hemifusion state formed by point mutants G1S and E11A [14,25]
is a kinetically trapped stalk that forms a stable complex with the
peptide bundle. Notably, the transmembrane domain of influenza
hemagglutinin (TMD) is also known to be involved in the
formation of the fusion pore [62–65]. In SNARE-mediated
membrane fusion such pore formation seems facilitated by the
end residues (C-termini) of the TMD, which are being pulled
Figure 8. The G1S mutation reverses the stalk elongation process facilitated by the wild-type. Notice the removal of solvent (colored
blue) and lipid head-groups (colored tan) from the membrane interior when the peptide bundle ‘reseals’ itself – the stalk and peptide are competitive
lineactants.
doi:10.1371/journal.pone.0038302.g008
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(see [39] for a recent review). A similar scenario may apply to
influenza fusion. If the fusion peptide indeed facilitate the fusion
process up to the formation of the HD, with the C-terminus of the
TMD being chiefly involved in the subsequent pore opening, this
would explain why the influenza fusion mechanism is relatively
insensitive to overall changes in TMD sequence or length [62–65].
In such a case, the ability of hemagglutinin to complete fusion
mainly relates to the ability of the C-terminus to perforate the
membrane (HD). The latter would, e.g., be affected by altering the
hydrophobicity, electrostatics or size of the TMD C-terminus and/
or cytoplasmic domain [66]. We predict that the trapped
hemifusion state that is due to substantial shortening of the
hemagglutinin TMD [62,63] or mutations herein [64–66], is a
kinetically trapped p-shaped hemifusion diaphragm. Future cryo-
tomography studies should be able to resolve these different
hemifused structures.
In this work we have mainly focused on how the peptides
stabilize the stalk and drive its expansion into the hemifusion
diaphragm. We have thus far not discussed the process of stalk
formation itself. Molecular simulations suggest that stalk formation
is facilitated by the formation of splayed lipid intermediates (i.e.,
the stalk barrier) which form a bridge between the apposed leaflets
[30,44–46]. Recent coarse grained and atomistic simulations have
revealed that the wild-type peptide induces a substantial disorder
in the packing of the lipid tails (tail protrusions) and thereby
substantially reduces the membrane thickness [22,46,67]. The
non-fusogenic mutants, however, show a less pronounced distor-
tion of the membrane integrity [22]. The absorbed wild-type
peptide induces an approximately 5-fold increase in the normal
tail protrusion frequency [46], i.e. a tail-end reaches the lipid
Figure 9. Interaction between multiple peptide bundles. (upper panel) Four wild-type bundles (top-view). The bundles strongly repel each
other and maximize their separation distance in the course of the simulation. Eventually one of the bundles vanishes. (middle panel) Four G13A
mutant bundles. The bundles are attractive and their coalescence results in a ‘super’ bundle consisting of 10 trans-membrane arranged peptides.
(lower panel) Aggregation number of the largest bundle in the course of the simulation (Only the trans-membrane arranged peptide are counted).
The brown line shows a separate simulation where the G13A mutation is reversed after 20 ms (G13A -. wild-type). The wild-type ‘super’ bundle
readopts its usual size in the course of the simulation.
doi:10.1371/journal.pone.0038302.g009
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protrusions would enhance stalk formation directly via the
formation of splayed lipid intermediates, they are expected to
lower the apparent stalk barrier by, ln(5)kBT=1.6 kBT [46].
Notably, a larger peptide:lipid ratio likely enhances such effect
[67]. However, because of the logarithmic dependence, in order to
lower the stalk barrier, by e.g. 15–40 kBT, one would require an
106{1017 fold increase in the total protrusion frequency. Thus, it
seems rather unlikely that the wild-type peptide facilitates stalk
formation directly via tail protrusions. In addition, it is hard to
reconcile how protrusions, when only being involved in stalk
formation, would explain the action of the terminal hemifusion
mutants G1S/E11A and the leaky fusion mutant G13A. Tail
protrusions, or equivalently membrane thinning, reflect the
presence of stress. Apparently, the adsorption of the wild-type
peptide induces a substantial stress in the membrane. For a surface
adhered amphiphilic peptide, however, the ability to induce stress
is limited because the membrane will alternatively respond by
forming pores or trans-membrane arranged bundles (i.e., when the
peptides are lineactants) [50,51]. In addition, such building up of
surface stress causes competitive bending of the membrane [68].
Thus, the peptide-induced stress, i.e. the observed protrusions/
thinning, might also facilitate other processes such as bundle, pore
and dimple formation [7,52].
With the dimple being hypothesized as a highly fusogenic and
thus very transient intermediate in membrane fusion, one would
not expect its direct observation. However, the observation of
(intact) dimples by cryo-electron microscopy in wild-type influenza
fusion [7] suggests that these dimples are in fact long-lived states
with a slow escape rate – they are quite resistant to fusion. We
Figure 10. Detailed view of the ‘super’ bundle (10 ms) formed by the leaky fusion mutant G13A (Top view, cross-section
through the bilayer center). Notice that residue 13 (colored green) directly faces the hydrophobic lipid rim around the bundle. The solvent
(colored blue) in the center of the bundle suggests the occurrence of leakage prior to lipid mixing [11].
doi:10.1371/journal.pone.0038302.g010
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stalk barrier, mainly depends on the distance between the
opposing leaflets and is rather independent of the leaflet’s
curvature [20,39,69]. Thus, the important role of the dimple is
to bring the leaflets into close proximity. To this aim, a dimple
lowers the energetic cost of leaflet approach, i.e. the inter-
membrane repulsion, both by reducing the effective contact area
of the fusion site and by increasing its surface hydrophobicity (i.e.,
curvature stress) [39]. Its direct observation, however, suggests that
the peptide-coated dimple might not suffice in bringing the
membranes sufficiently close. In these experiments [6,7], fusion
was only observed after formation of a funnel-like intermediate in
the target membrane. Notably, a bundle allows an additional
proximity by tilting the membrane and such a ‘volcano’ structure
substantially eases stalk formation (see Fig. S3).
To this end, our simulations offer a new interpretation for a
number of known features of the fusion reaction mediated by the
prototype fusion protein, influenza hemagglutinin, and might
bring new insights into mechanisms of other viral fusion
reactions. We hypothesize that such a line-tension controlled
fusion mechanism, which closely resembles the mechanism of
electrofusion [43], might be the direct evolutionary consequence
of the substantial free-energy barriers [4,5,27] that the viral
fusion machinery faces in its attempt to fuse with membranes
that are, in turn, evolutionary designed to be largely resistant to
(viral) fusion.
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Methods
Pore- and Stalk Formation
The hydrophilic pore of radius R=2.0 nm, located in one of
the bilayers, was stabilized using an repulsive potential U(ri) with
U(ri)~1=2k(ri{R)
2,i frivR and U(ri)~0 if ri§R, where ri
denotes the distance of the center of mass of the lipid from the pore
center and k a force constant (k=50kJnm {2 mol{1) [41,70].
Likewise, we induced the initial stalk in the bilayer fusion setup by
applying an external field. Here, we applied the same harmonic
potential to induce a R=1.0 nm ‘void’ in the solvent layer
between the bilayers. The hydrophobic nature of the void attracts
the lipid tails in the adjacent leaflets and results in the formation of
a stalk. After the stalk formation, the external field has been
removed to allow for an additional 4 ns equilibration of the stalk
structure.
Peptide Model
All peptides used consisted of 20 aminoacids: GLFGAIAG-
FIENGWEGMIDG (wild-type). The Martini coarse-grained
model [28,29] captures the specific nature of each individual
amino acid but does not predict secondary structure. The
secondary structure and protonation state of the wild-type
peptide (pdb:1IBN) and mutants (pdb:16OP, pdb:2DCI,
pdb:16OO, pdb:2L4G) were derived from the NMR-resolved
structures [15,71]. The secondary structure was modeled by both
restraining proper dihedrals between four neighboring backbone
beads with an harmonic potential and by altering the non-
bonded interactions according to the imposed secondary
structure (free in solution, or in a coil or bend the backbone
has a more polar character than in a helix or b-strand). Further
details concerning this methodology can be found in the original
publication [29]. To reproduce the experimentally observed
‘fixed’ angle between the two helices (the boomerang shape)
[15,22,71] additional dihedral angle potentials were explicitly
introduced for the backbone beads of residue 8 to 16. Further
details are given in Ref. [23]. Recent atomistic simulations
suggested that the ‘kink’ is in fact less preserved in the G1S
mutant than in the wild-type [22]. We corrected for the latter
effect by allowing a slightly larger flexibility between the two
helices (i.e., without the additional dihedral restraints). For
mutant G13A, an additional elastic network (Force constant of
500 kJ nm{2 Mol{1) between the nearest backbone beads
(cutoff between 0.5–0.9 nm) was applied to conserve its shallow
150 degrees tilt angle. Atomistic simulations of the wild-type in
an implicit membrane environment suggested that the NMR-
derived kink (secondary structure) is altered when the peptides
closely pack into an trans-membrane arranged bundle/oligomer
[72]. Although such prediction is beyond the capability of our
model, we emphasize that both a linear and kinked wild-type
peptide stabilizes the bundle in our simulations (see the section
about mutant G1V), whereas a linear or kinked G1V mutant
does not.
Peptide Bundle
Stable peptides pores were formed by simulating 8 peptides,
adhered to the membrane surface of a 10|10 nm POPC bilayer
(128 lipids), in the presence of externally stabilized hydrophilic
pores with a diameter of 2–3 nm (see above). The peptides (both
wild types and mutants) showed a remarkable attraction towards
the pore’s rim. The external pore-stabilizing potential was
removed after all peptides were assembled into the pore. We
found that at least 4 peptides were required to form self-stabilized
bundles. We additionally tested such scenario in pure DOPC,
pure DOPE and pure POPE bilayers and found that the formed
bundles were stable in all cases. Furthermore, these wild-type
bundles were found to be stable at both 310 and 350 K in the
course of the 10 ms simulation (in total about 20 simulations were
preformed). In addition, we also tested the stability of the wild-
type bundle with all the peptides oriented in the same direction,
and the stability of the bundle in the polar Martini forcefield [73]
in the presence of long-range electrostatic effects (PME). In all
cases the bundle was found to be stable.
To investigate the stability of the mutant bundles, the G1S,
G1V, and W14A mutations were performed on the stable and
equilibrated wild-type bundle (at 350 K). Statistics was collected
by performing multiple simulations (5 for each mutant) with
different starting velocities.
Bundle-facilitated Stalk Elongation
The bundle-facilitated stalk elongation was performed within
the same system as the hydrophilic pore facilitated stalk
elongation (DOPC, 1152 lipids per membrane, 16 water
molecules per lipid within the inter-membrane space). Here, a
pre-formed and equilibrated bundle was carefully embedded in a
constructed pore and was additionally equilibrated for 40 ns.
Then the stalk was induced according to the procedure described
above. To be able to capture the bundle-facilitated stalk
elongation (which is a nucleated event) within the limited time
scales of the simulation, the simulations were performed at a
slightly elevated temperature of 350 K (instead of 310 K). We
emphasize that the absence of the bundle or pore also
destabilizes the stalk at 350 K.
The G1S mutation was performed on the readily equilibrated
‘stalk-bundle’ setup of the wild-type. Statistics was collected by
performing multiple simulations (5 with for each) with different
starting velocities.
Influenza Fusion Mechanism
PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38302Coalescence of the G13A Bundles
Here, a POPC membrane (128 lipids) with an equilibrated wild-
type bundle (consisting of 6 trans-membrane arranged peptides
and 2 ‘bystander’ peptides) was copied in both the X and Y
dimension. The G13A mutation was performed on this system.
Both wild-type and G13A mutant simulations were run at 310 K.
For the reverse simulation (G13A to wild-type) the final snapshot
of the G13A simulation was taken, and the G13A mutation was
restored to the wild-type.
The peptide aggregation number of the largest bundle was
calculated using a cluster algorithm. This algorithm clustered all
back-bone atoms, which where located within +1.0 and 21.0 nm
from the membrane center, based on a distance cutoff of 2.0 nm.
Simulation Details
The simulations described in this paper were performed with
the GROMACS simulation package [74], version 4.0.5. We used
the Martini model version 2.1 [28,29] to simulate the lipids and
amino acids. In all simulations the system was coupled to a
constant temperature bath [75] at 310 or 350 K with a relaxation
time tT of 1.0 ps. The time step used in the simulation was 20 fs
[76]. Shifted potentials were used to describe van der Waals and
electrostatic pair-wise interactions. In both cases, the neighbor list
cutoff was 1.2 nm and these potentials were gradually shifted to
zero when the pair-wise distance exceeded 0.9 nm (van der Waals)
or 0 nm (Coulomb). The neighbor list was updated every 10
simulation steps. The pressure was weakly coupled [75] to 1 bar
with a relaxation time tP of 0.5 ps. In analogy to the other studies
employing the Martini model, time scales quoted in this work were
scaled by a factor of 4 to correct for the 4-times faster diffusion
rates of water and lipids in the coarse-grained model [28] with
respect to reality.
Supporting Information
Figure S1 Calculation of the line-tension of the elongat-
ed stalk and HD.
(TIF)
Figure S2 Splayed lipid intermediate observed before
the stalk disappears.
(TIF)
Figure S3 Bundle-mediated stalk formation.
(TIF)
Figure S4 Additional bundle-mediated fusion simula-
tions.
(TIF)
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